Australia is close to approving COVID-19 vaccinations for children aged between six months to five years after the Therapeutic Goods Administration (TGA) granted provisional determination to Pfizer.
This will be the first step to gaining registration on the Register of Therapeutic Goods for Pfizer, along with Moderna’s SpikeVax.
“Approval and potential supply in Australia would only commence should the vaccine be approved as safe and effective by the TGA and recommended for administration to this age group by the [Australian Technical Advisory Group on Immunisation],” according to a statement from the TGA.
“It does not mean an application for use in this age group has been made, and it does not mean any subsequent application would be approved.”…